Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 03237H101 since 12/18/2024, newest first.
| Filer | % of Class | Filed | |
|---|---|---|---|
|
Perceptive Advisors LLC
13G/A
Amendment 4
|
7.5% |
5/15/2026
Event 3/31/2026
|
|
| Perceptive Advisors LLC | 7.5% | ||
| Joseph Edelman | 7.5% | ||
| Perceptive Life Sciences Master Fund, Ltd. | 7.5% | ||
| Vanguard Group Inc 13G/A Amendment 1 | 0% |
3/26/2026
Event 3/13/2026
|
|
|
TCG Crossover GP II, LLC
13G/A
Amendment 1
|
5.7% |
2/17/2026
Event 12/31/2025
|
|
| TCG Crossover GP II, LLC | 5.7% | ||
| TCG Crossover Fund II, L.P. | 5.7% | ||
| Chen Yu | 5.7% | ||
|
Adage Capital Management, L.P.
13G/A
Amendment 3
|
2.5% |
2/12/2026
Event 12/31/2025
|
|
| Adage Capital Management, L.P. | 2.5% | ||
| Robert Atchinson | 2.5% | ||
| Phillip Gross | 2.5% | ||
|
FMR LLC
13G/A
Amendment 1
|
15.0% |
2/5/2026
Event 12/31/2025
|
|
| FMR LLC | 15.0% | ||
| Abigail P. Johnson | 15.0% | ||
| Vanguard Group Inc 13G | 5.3% |
1/30/2026
Event 12/31/2025
|
|
| BlackRock, Inc. 13G/A Amendment 1 | 7.1% |
1/21/2026
Event 12/31/2025
|
|
|
Commodore Capital LP
13G
|
5.1% |
11/17/2025
Event 11/10/2025
|
|
| Commodore Capital LP | 5.1% | ||
| Commodore Capital Master LP | 5.1% | ||
| Robert Egen Atkinson | 5.1% | ||
| Michael Kramarz | 5.1% | ||
|
Perceptive Advisors LLC
13G/A
Amendment 3
|
8.2% |
11/14/2025
Event 9/30/2025
|
|
| Perceptive Advisors LLC | 8.2% | ||
| Joseph Edelman | 8.2% | ||
| Perceptive Life Sciences Master Fund, Ltd. | 8.2% | ||
|
Point72 Asset Management, L.P.
13G/A
Amendment 1
|
2.6% |
11/14/2025
Event 9/30/2025
|
|
| Point72 Asset Management, L.P. | 2.6% | ||
| Point72 Capital Advisors, Inc. | 2.6% | ||
| Steven A. Cohen | 2.6% | ||
|
Adage Capital Management, L.P.
13G/A
Amendment 2
|
6.4% |
11/13/2025
Event 9/30/2025
|
|
| Adage Capital Management, L.P. | 6.4% | ||
| Robert Atchinson | 6.4% | ||
| Phillip Gross | 6.4% | ||
| Vanguard Group Inc 13G/A Amendment 1 | 4.9% |
10/30/2025
Event 9/30/2025
|
|
|
FMR LLC
13G
|
10.7% |
10/7/2025
Event 9/30/2025
|
|
| FMR LLC | 10.7% | ||
| Abigail P. Johnson | 10.7% | ||
|
Adage Capital Management, L.P.
13G/A
Amendment 1
|
9.9% |
8/12/2025
Event 6/30/2025
|
|
| Adage Capital Management, L.P. | 9.9% | ||
| Robert Atchinson | 9.9% | ||
| Phillip Gross | 9.9% | ||
| Vanguard Group Inc 13G | 5.0% |
7/29/2025
Event 6/30/2025
|
|
| BlackRock, Inc. 13G | 5.5% |
7/17/2025
Event 6/30/2025
|
|
|
Point72 Asset Management, L.P.
13G
|
5.3% |
6/25/2025
Event 6/24/2025
|
|
| Point72 Asset Management, L.P. | 5.3% | ||
| Point72 Capital Advisors, Inc. | 5.3% | ||
| Steven A. Cohen | 5.3% | ||
|
Perceptive Advisors LLC
13G/A
Amendment 2
|
8.8% |
5/15/2025
Event 3/31/2025
|
|
| Perceptive Advisors LLC | 8.8% | ||
| Joseph Edelman | 8.8% | ||
| Perceptive Life Sciences Master Fund, Ltd. | 8.8% | ||
|
Point72 Asset Management, L.P.
13G/A
Amendment 1
|
1.2% |
5/15/2025
Event 3/31/2025
|
|
| Point72 Asset Management, L.P. | 1.2% | ||
| Point72 Capital Advisors, Inc. | 1.2% | ||
| Steven A. Cohen | 1.2% | ||
|
Adage Capital Management, L.P.
13G
|
6.4% |
5/12/2025
Event 3/31/2025
|
|
| Adage Capital Management, L.P. | 6.4% | ||
| Robert Atchinson | 6.4% | ||
| Phillip Gross | 6.4% | ||
|
Panacea Innovation Ltd
13G/A
Amendment 1
|
2.6% |
2/14/2025
Event 12/31/2024
|
|
| Panacea Venture Healthcare Fund II, L.P. | 2.6% | ||
| Panacea Venture Healthcare Fund II GP Company, Ltd. | 2.6% | ||
| Panacea Innovation Limited | 2.6% | ||
| James Huang | 2.6% | ||
|
Perceptive Advisors LLC
13G/A
Amendment 1
|
7.9% |
2/14/2025
Event 12/31/2024
|
|
| Perceptive Advisors LLC | 7.9% | ||
| Joseph Edelman | 7.9% | ||
| Perceptive Life Sciences Master Fund, Ltd. | 7.9% | ||
|
Point72 Asset Management, L.P.
13G
|
5.6% |
1/14/2025
Event 1/13/2025
|
|
| Point72 Asset Management, L.P. | 5.6% | ||
| Point72 Capital Advisors, Inc. | 5.6% | ||
| Steven A. Cohen | 5.6% |
| Period | Filings | Shares, Excl. Options | Value, Excl. Options |
|---|---|---|---|
| 2026 Q3 | 6 | 12.6 k | $367 k |
| 2026 Q2 | 223 | 117 M | $2.15 B |
| 2026 Q1 | 184 | 115 M | $1.60 B |
| 2025 Q4 | 193 | 112 M | $1.36 B |
| 2025 Q3 | 180 | 112 M | $1.52 B |
| 2025 Q2 | 136 | 81.9 M | $525 M |
| 2025 Q1 | 141 | 73.9 M | $262 M |
| 2024 Q4 | 139 | 50.0 M | $189 M |
| 2024 Q3 | 120 | 43.6 M | $141 M |
| 2024 Q2 | 133 | 44.6 M | $84.8 M |
| 2024 Q1 | 183 | 54.1 M | $154 M |
| 2023 Q4 | 213 | 65.1 M | $958 M |
| 2023 Q3 | 195 | 59.6 M | $1.09 B |
| 2023 Q2 | 174 | 54.8 M | $1.18 B |
| 2023 Q1 | 170 | 51.6 M | $1.52 B |
| 2022 Q4 | 155 | 49.7 M | $1.83 B |
| 2022 Q3 | 123 | 37.8 M | $1.06 B |
| 2022 Q2 | 96 | 26.6 M | $513 M |
| 2022 Q1 | 78 | 23.4 M | $300 M |